Crossmark

PDL1 targeting by miR-138-5p amplifies anti-tumor immunity and Jurkat cells survival in non-small cell lung cancer

Published Online: 2024-06-12

Authors

Rostami, Fatemeh

Tavakol Hamedani, Zahra

Sadoughi, Azadeh

Mehrabadi, Marzieh

kouhkan, Fatemeh
License Information

Text and Data Mining valid from 2024-06-12

Version of Record valid from 2024-06-12
More Information

Article History

Received: 19 August 2023

Accepted: 13 May 2024

First Online: 12 June 2024

Competing interests

: The authors declare no competing interests.

Document is current